| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Anemia (Renal)ErythropoietinFerritinKidney (Chronic renal failure)| 1 | 2006 | Anemia in chronic kidney disease: causes, diagnosis, treatment. | 
| + | - | nl | Cleve Clin J Med 73(3):289-97 (2006) |
| 2 | 2008 | Anemia of chronic kidney disease. |
| + | - | nl | Clin J Am Soc Nephrol 3(1):3-6 (2008) |
| 3 | 2007 | Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. |
| + | - | nl | Clin J Am Soc Nephrol 2(6):1274-82 (2007) |
| 4 | 2006 | Assessing iron status: beyond serum ferritin and transferrin saturation. |
| + | - | nl | Clin J Am Soc Nephrol 1 Suppl 1(-):S4-8 (2006) |
| 5 | 2006 | Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease. |
| + | - | nl | Clin J Am Soc Nephrol 1 Suppl 1(-):S24-31 (2006) |
| 6 | 2006 | Acute injury with intravenous iron and concerns regarding long-term safety. |
| + | - | nl | Clin J Am Soc Nephrol 1 Suppl 1(-):S19-23 (2006) |
| 7 | 2006 | Do we know the correct hemoglobin target for anemic patients with chronic kidney disease? |
| + | - | nl | Clin J Am Soc Nephrol 1(4):678-84 (2006) |
| 8 | 2007 | Clinical aspects of iron use in the anemia of kidney disease. |
| + | - | nl | J Am Soc Nephrol 18(2):382-93 (2007) |
| 9 | 2007 | Management of anaemia in haemodialysis and peritoneal dialysis patients (chapter 8). |
| + | - | nl | Nephrol Dial Transplant 22 Suppl 7(-):vii78-104 (2007) |
| 10 | 2004 | Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. |
| + | - | nl | Nephrol Dial Transplant 19 Suppl 2(-):ii1-47 (2004) |
| 11 | 2000 | European best practice guidelines 17-18: adverse effects. |
| + | - | nl | Nephrol Dial Transplant 15 Suppl 4(-):51-6 (2000) |
| 12 | 2000 | European best practice guidelines 14-16: inadequate response to epoetin. |
| + | - | nl | Nephrol Dial Transplant 15 Suppl 4(-):43-50 (2000) |
| 13 | 2000 | European best practice guidelines 9-13: anaemia management. |
| + | - | nl | Nephrol Dial Transplant 15 Suppl 4(-):33-42 (2000) |
| 14 | 2000 | European best practice guidelines 6-8: assessing and optimizing iron stores. |
| + | - | nl | Nephrol Dial Transplant 15 Suppl 4(-):20-32 (2000) |
| 15 | 2000 | European best practice guidelines 5: target haemoglobin. |
| + | - | nl | Nephrol Dial Transplant 15 Suppl 4(-):15-9 (2000) |
| 16 | 2000 | European best practice guidelines 1-4: evaluating anaemia and initiating treatment. |
| + | - | nl | Nephrol Dial Transplant 15 Suppl 4(-):8-14 (2000) |
| 17 | 2000 | Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy. |
| + | - | nl | Nephrol Dial Transplant 15 Suppl 3(-):36-9 (2000) |
| 18 | 1998 | Iron supplementation in haemodialysis--practical clinical guidelines. |
| + | - | nl | Nephrol Dial Transplant 13(10):2572-7 (1998) |
| 19 | 1985 | Anemia of end-stage renal disease (ESRD). |
| + | - | nl | Kidney Int 28(1):1-5 (1985) |
| 20 | 2010 | Importance of ferritin for optimizing anemia therapy in chronic kidney disease. |
| + | - | nl | Am J Nephrol 32(5):439-46 (2010) |
| 21 | 2005 | Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin. |
| + | - | nl | Nephrol Dial Transplant 20 Suppl 3(-):iii25-32 (2005) |
| 22 | 2005 | Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years. |
| + | - | nl | Nephrol Dial Transplant 20 Suppl 3(-):iii3-24 (2005) |
